A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2011
This is a Phase 1, pharmacokinetic and pharmacodynamic study of intravenous and subcutaneous administered golimumab in patients with rheumatoid arthritis.
Epistemonikos ID: fbad61ec7e414b36343e7674139fee8fa6137389
First added on: Mar 23, 2022